165 related articles for article (PubMed ID: 33668070)
1. Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Cruz-Lagunas A; Thapa M; Fernández-López LA; Carnalla-Cortés M; Choreño-Parra EM; Mena-Hernández L; Sandoval-Vega M; Hernández-Montiel EM; Hernández-García DL; Ramírez-Noyola JA; Reyes-López CE; Domínguez-Faure A; Zamudio-López GY; Márquez-García E; Moncada-Morales A; Mendoza-Milla C; Cervántes-Rosete D; Muñoz-Torrico M; Luna-Rivero C; García-Latorre EA; Guadarrama-Ortíz P; Ávila-Moreno F; Domínguez-Cherit G; Rodríguez-Reyna TS; Mudd PA; Hernández-Cárdenas CM; Khader SA; Zúñiga J
J Infect Dis; 2021 Jul; 224(1):21-30. PubMed ID: 33668070
[TBL] [Abstract][Full Text] [Related]
2. CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Choreño-Parra JA; Jiménez-Álvarez LA; Ramírez-Martínez G; Sandoval-Vega M; Salinas-Lara C; Sánchez-Garibay C; Luna-Rivero C; Hernández-Montiel EM; Fernández-López LA; Cabrera-Cornejo MF; Choreño-Parra EM; Cruz-Lagunas A; Domínguez A; Márquez-García E; Cabello-Gutiérrez C; Bolaños-Morales FV; Mena-Hernández L; Delgado-Zaldivar D; Rebolledo-García D; Guadarrama-Ortiz P; Regino-Zamarripa NE; Mendoza-Milla C; García-Latorre EA; Rodiguez-Reyna TS; Cervántes-Rosete D; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
Front Immunol; 2021; 12():633297. PubMed ID: 33717172
[TBL] [Abstract][Full Text] [Related]
3. Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection.
Nishida S; Fukazawa R; Imai T; Takeda S; Hayakawa J; Takeuchi H; Shimizu K; Kawakami Y; Takase M
Pediatr Int; 2011 Dec; 53(6):910-4. PubMed ID: 21605280
[TBL] [Abstract][Full Text] [Related]
4. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
Front Immunol; 2021; 12():593595. PubMed ID: 33995342
[TBL] [Abstract][Full Text] [Related]
6. Could SP-A and SP-D Serum Levels Predict COVID-19 Severity?
Maddaloni L; Zullino V; Bugani G; Lazzaro A; Brisciani M; Mastroianni CM; Santinelli L; Ruberto F
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891806
[TBL] [Abstract][Full Text] [Related]
7. Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection.
Delgado C; Krötzsch E; Jiménez-Alvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Morán J; Hernández C; Sierra-Vargas P; Avila-Moreno F; Becerril C; Montaño M; Bañales-Méndez JL; Zúñiga J; Buendía-Roldán I
Lung; 2015 Feb; 193(1):25-30. PubMed ID: 25537934
[TBL] [Abstract][Full Text] [Related]
8. Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.
Deng LS; Yuan J; Ding L; Chen YL; Zhao CH; Chen GQ; Li XH; Li XH; Luo WT; Lan JF; Tan GY; Tang SH; Xia JY; Liu X
Infect Dis Poverty; 2020 Dec; 9(1):163. PubMed ID: 33261654
[TBL] [Abstract][Full Text] [Related]
9. Coinfection With SARS-CoV-2 and Influenza A(H1N1) in a Patient Seen at an Influenza-like Illness Surveillance Site in Egypt: Case Report.
Fahim M; Ghonim HAES; Roshdy WH; Naguib A; Elguindy N; AbdelFatah M; Hassany M; Mohsen A; Afifi S; Eid A
JMIR Public Health Surveill; 2021 Apr; 7(4):e27433. PubMed ID: 33784634
[TBL] [Abstract][Full Text] [Related]
10. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
[TBL] [Abstract][Full Text] [Related]
11. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.
Zheng J; Chen F; Wu K; Wang J; Li F; Huang S; Lu J; Huang J; Liu H; Zhou R; Huang Z; Meng B; Yuan Z; Wu X
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009997. PubMed ID: 34843492
[TBL] [Abstract][Full Text] [Related]
12. Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.
Nikolaidis NM; White MR; Allen K; Tripathi S; Qi L; McDonald B; Taubenberger J; Seaton BA; McCormack FX; Crouch EC; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(11):L1036-44. PubMed ID: 24705721
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Critical Care Occupancy and Outcomes of Critically Ill Patients during the 2020 COVID-19 Winter Surge and 2009 H1N1 Influenza Pandemic in Australia.
Serpa Neto A; Burrell AJC; Bailey M; Broadley T; Cooper DJ; French CJ; Pilcher D; Plummer MP; Trapani T; Webb SA; Bellomo R; Udy A
Ann Am Thorac Soc; 2021 Aug; 18(8):1380-1389. PubMed ID: 33356988
[No Abstract] [Full Text] [Related]
14. The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.
Alay H; Laloglu E
J Med Virol; 2021 Oct; 93(10):6008-6015. PubMed ID: 34232533
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein B gene polymorphism is associated with severe influenza.
To KKW; Zhou J; Song YQ; Hung IFN; Ip WCT; Cheng ZS; Chan ASF; Kao RYT; Wu AKL; Chau S; Luk WK; Ip MSM; Chan KH; Yuen KY
Chest; 2014 Jun; 145(6):1237-1243. PubMed ID: 24337193
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Co-infection with SARS-CoV-2 and influenza H1N1 in a patient with acute respiratory distress syndrome and a pulmonary sarcoidosis.
Baala L; Benzekri-Lefevre D; Bret L; Guillaume C; Courtellemont L; El Khalil A; Guery T; Iquel S; Perche O; Khadre K; Brungs T; Decker J; Francia T; Bois J; Delamare B; Guinard J; Got L; Briault S; Boulain T; Legac E
F1000Res; 2020; 9():1482. PubMed ID: 35528205
[TBL] [Abstract][Full Text] [Related]
17. Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures.
Kulasinghe A; Tan CW; Ribeiro Dos Santos Miggiolaro AF; Monkman J; SadeghiRad H; Bhuva DD; Motta Junior JDS; Busatta Vaz de Paula C; Nagashima S; Baena CP; Souza-Fonseca-Guimaraes P; de Noronha L; McCulloch T; Rossi GR; Cooper C; Tang B; Short KR; Davis MJ; Souza-Fonseca-Guimaraes F; Belz GT; O'Byrne K
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675048
[TBL] [Abstract][Full Text] [Related]
18. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.
Job ER; Deng YM; Tate MD; Bottazzi B; Crouch EC; Dean MM; Mantovani A; Brooks AG; Reading PC
J Immunol; 2010 Oct; 185(7):4284-91. PubMed ID: 20817882
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
[TBL] [Abstract][Full Text] [Related]
20. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
